NCT04890613 - Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous...
Fill out the form below and we'll forward your information to the study team. They will contact you directly about eligibility and next steps.
Please confirm you meet the basic requirements for this trial:
Your information will be forwarded directly to the study team listed for this trial. By submitting, you consent to being contacted about this research study.
FDA Disclaimer: This service provides trial information only. Participation eligibility is determined by study investigators. All clinical trials require IRB (Institutional Review Board) approval to protect the rights and welfare of research subjects.
Back to search